Healthcare -
Biotechnology - NYSE - CH
$ 1.635
-7.1 %
$ 158 M
Market Cap
-0.68
P/E
ADCT - GROSS PROFIT
Gross Profit ADCT - ADC Therapeutics SA
67 M
LAST VALUE
43.56%
2 YEAR CAGR
20.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR